Investor Relations

OPKO Announces Presentation of Data on Long-Acting Oxyntomodulin at Diabetes Conference more »

OPKO Acquires Next Generation Dry Powder Inhaler to Treat Respiratory Disorders more »

OPKO Health Announces Key Executive Appointments for Renal Division more »

OPKO Health Announces Executive Appointments more »

Investor FAQs